{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:49:19Z","timestamp":1793828959490,"version":"4.6.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41585-022-00642-w","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T11:05:14Z","timestamp":1662548714000},"page":"681-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction"],"prefix":"10.1038","volume":"19","author":[{"given":"Lori A.","family":"Birder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin K.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"642_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nrurol.2017.53","volume":"14","author":"W Gibson","year":"2017","unstructured":"Gibson, W. & Wagg, A. Incontinence in the elderly, \u2018normal\u2019 ageing, or unaddressed pathology? Nat. Rev. Urol. 14, 440\u2013447 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"642_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1532-5415.2005.00613.x","volume":"54","author":"MH Pfisterer","year":"2006","unstructured":"Pfisterer, M. H., Griffiths, D. J., Schaefer, W. & Resnick, N. M. The effect of age on lower urinary tract function: a study in women. J. Am. Geriatr. Soc. 54, 405\u2013412 (2006).","journal-title":"J. Am. Geriatr. Soc."},{"key":"642_CR3","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0022-5347(05)00311-3","volume":"175","author":"CE Dubeau","year":"2006","unstructured":"Dubeau, C. E. The aging lower urinary tract. J. Urol. 175, S11\u2013S15 (2006).","journal-title":"J. Urol."},{"key":"642_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.eururo.2008.03.109","volume":"54","author":"CR Chapple","year":"2008","unstructured":"Chapple, C. R. et al. Lower urinary tract symptoms revisited: a broader clinical perspective. Eur. Urol. 54, 563\u2013569 (2008).","journal-title":"Eur. Urol."},{"key":"642_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.suc.2016.02.003","volume":"96","author":"RC McDonough","year":"2016","unstructured":"McDonough, R. C. & Ryan, S. T. Diagnosis and management of lower urinary tract dysfunction. Surg. Clin. North Am. 96, 441\u2013452 (2016).","journal-title":"Surg. Clin. North Am."},{"key":"642_CR6","first-page":"S3","volume":"5","author":"N Yoshimura","year":"2003","unstructured":"Yoshimura, N. & Chancellor, M. B. Neurophysiology of lower urinary tract function and dysfunction. Rev. Urol. 5, S3\u2013S10 (2003).","journal-title":"Rev. Urol."},{"key":"642_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0090-4295(01)01298-5","volume":"58","author":"SJ Jacobsen","year":"2001","unstructured":"Jacobsen, S. J., Girman, C. J. & Lieber, M. M. Natural history of benign prostatic hyperplasia. Urology 58, 5\u201316 (2001).","journal-title":"Urology"},{"key":"642_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.eururo.2004.04.005","volume":"46","author":"BL Hansen","year":"2004","unstructured":"Hansen, B. L. Lower urinary tract symptoms (LUTS) and sexual function in both sexes. Eur. Urol. 46, 229\u2013334 (2004).","journal-title":"Eur. Urol."},{"key":"642_CR9","first-page":"64","volume":"1","author":"KM Azadzoi","year":"2013","unstructured":"Azadzoi, K. M. & Siroky, M. B. Mechanisms of lower urinary tract symptoms in pelvic ischemia. J. Biochem. Pharmacol. Res. 1, 64\u201374 (2013).","journal-title":"J. Biochem. Pharmacol. Res."},{"key":"642_CR10","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1002\/nau.24313","volume":"39","author":"JE Speich","year":"2020","unstructured":"Speich, J. E. et al. Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Neurourol. Urodyn. 39, S16\u2013S22 (2020).","journal-title":"Neurourol. Urodyn."},{"key":"642_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1242\/jeb.132142","volume":"220","author":"D Munro","year":"2017","unstructured":"Munro, D. & Treberg, J. R. A radical shift in perspective: mitochondria as regulators of reactive oxygen species. J. Exp. Biol. 220, 1170\u20131180 (2017).","journal-title":"J. Exp. Biol."},{"key":"642_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1469-7793.2000.00057.x","volume":"529","author":"MR Duchen","year":"2000","unstructured":"Duchen, M. R. Mitochondria and calcium: from cell signaling to cell death. J. Physiol. 529, 57\u201368 (2000).","journal-title":"J. Physiol."},{"key":"642_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/cc6779","volume":"12","author":"H Bayir","year":"2008","unstructured":"Bayir, H. & Kagan, V. E. Bench to bedside: mitochondrial injury, oxidative stress and apoptosis. Crit. Care 12, 206 (2008).","journal-title":"Crit. Care"},{"key":"642_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","volume":"29","author":"E Cadenas","year":"2000","unstructured":"Cadenas, E. & Davies, K. J. Mitochondrial free radical generation, oxidative stress and aging. Free Rad. Biol. Med. 29, 222\u2013230 (2000).","journal-title":"Free Rad. Biol. Med."},{"key":"642_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells9030785","volume":"9","author":"WI Effendi","year":"2020","unstructured":"Effendi, W. I., Nagano, T., Kobayashi, K. & Nishimura, Y. Focusing on adenosine receptors as a potential targeted therapy in human diseases. Cells 9, 24 (2020).","journal-title":"Cells"},{"key":"642_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1124\/jpet.116.237552","volume":"359","author":"EK Jackson","year":"2016","unstructured":"Jackson, E. K., Gillespie, D. G. & Mi, Z. 8-Aminoguanosine and 8-aminoguanine exert diuretic, natriuretic, glucosuric, and antihypertensive activity. J. Pharmacol. Exp. Ther. 359, 420\u2013435 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"642_CR17","unstructured":"Jackson, E. K. & Tofovic, S. P. Methods for treatment using small molecule potassium-sparing diuretics and natriuretics. US Patent No. 10,729,711 (2020)."},{"key":"642_CR18","first-page":"63","volume":"59","author":"WR Osborne","year":"1986","unstructured":"Osborne, W. R. & Barton, R. W. A rat model of purine nucleoside phosphorylase deficiency. Immunology 59, 63\u201367 (1986).","journal-title":"Immunology"},{"key":"642_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1124\/jpet.117.243758","volume":"363","author":"EK Jackson","year":"2017","unstructured":"Jackson, E. K. & Mi, Z. 8-Aminoguanosine exerts diuretic, natriuretic, and glucosuric activity via conversion to 8-aminoguanine, yet has direct antikaliuretic effects. J. Pharmacol. Exp. Ther. 363, 358\u2013366 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"642_CR20","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1021\/jm00060a010","volume":"36","author":"JW Chern","year":"1993","unstructured":"Chern, J. W. et al. Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase. J. Med. Chem. 36, 1024\u20131031 (1993).","journal-title":"J. Med. Chem."},{"key":"642_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010085","volume":"7","author":"EK Jackson","year":"2018","unstructured":"Jackson, E. K., Mi, Z., Kleyman, T. R. & Cheng, D. 8-Aminoguanine induces diuresis, natriuresis, and glucosuria by inhibiting purine nucleoside phosphorylase and reduces potassium excretion by inhibiting Rac1. J. Am. Heart Assoc. 7, e010085 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"642_CR22","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata, S. et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat. Med. 14, 1370\u20131376 (2008).","journal-title":"Nat. Med."},{"key":"642_CR23","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1172\/JCI43124","volume":"121","author":"S Shibata","year":"2011","unstructured":"Shibata, S. et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J. Clin. Invest. 121, 3233\u20133243 (2011).","journal-title":"J. Clin. Invest."},{"key":"642_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0163-7258(00)00097-8","volume":"88","author":"A Bzowska","year":"2000","unstructured":"Bzowska, A., Kulikowska, E. & Shugar, D. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol. Ther. 88, 349\u2013425 (2000).","journal-title":"Pharmacol. Ther."},{"key":"642_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cccn.2004.02.008","volume":"344","author":"EL Roberts","year":"2004","unstructured":"Roberts, E. L., Newton, R. P. & Axford, A. T. Plasma purine nucleoside phosphorylase in cancer patients. Clin. Chim. Acta 344, 109\u2013114 (2004).","journal-title":"Clin. Chim. Acta"},{"key":"642_CR26","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1023\/B:NERE.0000042209.02324.98","volume":"29","author":"RG Silva","year":"2004","unstructured":"Silva, R. G. et al. Purine nucleoside phosphorylase activity in rat cerebrospinal fluid. Neurochem. Res. 29, 1831\u20131835 (2004).","journal-title":"Neurochem. Res."},{"key":"642_CR27","doi-asserted-by":"publisher","first-page":"101882","DOI":"10.1016\/j.redox.2021.101882","volume":"41","author":"M Bortolotti","year":"2021","unstructured":"Bortolotti, M., Polito, L., Battelli, M. G. & Bolognesi, A. Xanthine oxidoreductase: one enzyme for multiple physiological tasks. Redox Biol. 41, 101882 (2021).","journal-title":"Redox Biol."},{"key":"642_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/0-306-46843-3_22","volume":"486","author":"FF Snyder","year":"2000","unstructured":"Snyder, F. F., Yuan, R. G., Bin, J. C., Carter, K. L. & McKay, D. J. Human guanine deaminase: cloning, expression and characterisation. Adv. Exp. Med. Biol. 486, 111\u2013114 (2000).","journal-title":"Adv. Exp. Med. Biol."},{"key":"642_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/jci.insight.140109","volume":"5","author":"LA Birder","year":"2020","unstructured":"Birder, L. A. et al. Purine nucleoside phosphorylase inhibition ameliorates age-associated lower urinary tract dysfunctions. JCI Insight 5, 15 (2020).","journal-title":"JCI Insight"},{"key":"642_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.tips.2004.01.006","volume":"25","author":"G Hask\u00f3","year":"2004","unstructured":"Hask\u00f3, G., Sitkovsky, M. V. & Szab\u00f3, C. Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol. Sci. 25, 152\u2013157 (2004).","journal-title":"Trends Pharmacol. Sci."},{"key":"642_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/mds.26483","volume":"31","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya, S. et al. Oral inosine persistently elevates plasma antioxidant capacity in Parkinson\u2019s disease. Mov. Disord. 31, 417\u2013421 (2016).","journal-title":"Mov. Disord."},{"key":"642_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.neuroscience.2014.05.038","volume":"274","author":"S Cipriani","year":"2014","unstructured":"Cipriani, S., Bakshi, R. & Schwarzschild, M. A. Protection by inosine in a cellular model of Parkinson\u2019s disease. Neuroscience 274, 242\u2013249 (2014).","journal-title":"Neuroscience"},{"key":"642_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10715760310001629056","volume":"38","author":"DP Gelain","year":"2004","unstructured":"Gelain, D. P. et al. Extracellular inosine is modulated by H2O2 and protects Sertoli cells against lipoperoxidation and cellular injury. Free Radic. Res. 38, 37\u201347 (2004).","journal-title":"Free Radic. Res."},{"key":"642_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1667\/RR3552.1","volume":"165","author":"SV Gudkov","year":"2006","unstructured":"Gudkov, S. V., Shtarkman, I. N., Smirnova, V. S., Chernikov, A. V. & Bruskov, V. I. Guanosine and inosine display antioxidant activity, protect DNA in vitro from oxidative damage induced by reactive oxygen species, and serve as radioprotectors in mice. Radiat. Res. 165, 538\u2013545 (2006).","journal-title":"Radiat. Res."},{"key":"642_CR35","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10787-018-0476-y","volume":"26","author":"P Ruhal","year":"2018","unstructured":"Ruhal, P. & Dhingra, D. Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats. Inflammopharmacology 26, 1317\u20131329 (2018).","journal-title":"Inflammopharmacology"},{"key":"642_CR36","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00213-019-05419-5","volume":"237","author":"FC Teixeira","year":"2020","unstructured":"Teixeira, F. C. et al. Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: a nucleoside with multitarget brain actions. Psychopharmacology 237, 811\u2013823 (2020).","journal-title":"Psychopharmacology"},{"key":"642_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11302-015-9475-2","volume":"11","author":"B Bellaver","year":"2015","unstructured":"Bellaver, B. et al. Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway. Purinergic Signal. 11, 571\u2013580 (2015).","journal-title":"Purinergic Signal."},{"key":"642_CR38","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1007\/s12035-016-0238-z","volume":"54","author":"RDR Gerbatin","year":"2017","unstructured":"Gerbatin, R. D. R. et al. Guanosine protects against traumatic brain injury-induced functional impairments and neuronal loss by modulating excitotoxicity, mitochondrial dysfunction, and inflammation. Mol. Neurobiol. 54, 7585\u20137596 (2017).","journal-title":"Mol. Neurobiol."},{"key":"642_CR39","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s12035-014-8978-0","volume":"52","author":"G Hansel","year":"2015","unstructured":"Hansel, G. et al. Guanosine protects against cortical focal ischemia. involvement of inflammatory response. Mol. Neurobiol. 52, 1791\u20131803 (2015).","journal-title":"Mol. Neurobiol."},{"key":"642_CR40","doi-asserted-by":"publisher","first-page":"102049","DOI":"10.1016\/j.pupt.2021.102049","volume":"69","author":"Y Luo","year":"2021","unstructured":"Luo, Y. et al. Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-kappaB signals in OVA-induced asthmatic mice. Pulm. Pharmacol. Ther. 69, 102049 (2021).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"642_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10787-018-0506-9","volume":"27","author":"MG Zizzo","year":"2019","unstructured":"Zizzo, M. G. et al. Preventive effects of guanosine on intestinal inflammation in 2, 4-dinitrobenzene sulfonic acid (DNBS)-induced colitis in rats. Inflammopharmacology 27, 349\u2013359 (2019).","journal-title":"Inflammopharmacology"},{"key":"642_CR42","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.neuint.2013.01.019","volume":"62","author":"P Albrecht","year":"2013","unstructured":"Albrecht, P. et al. Extracellular cyclic GMP and its derivatives GMP and guanosine protect from oxidative glutamate toxicity. Neurochem. Int. 62, 610\u2013619 (2013).","journal-title":"Neurochem. Int."},{"key":"642_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/jnc.12324","volume":"126","author":"T Dal-Cim","year":"2013","unstructured":"Dal-Cim, T. et al. Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. J. Neurochem. 126, 437\u2013450 (2013).","journal-title":"J. Neurochem."},{"key":"642_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.neuint.2012.05.021","volume":"61","author":"T Dal-Cim","year":"2012","unstructured":"Dal-Cim, T. et al. Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K\/Akt\/GSK-3beta pathway. Neurochem. Int. 61, 397\u2013404 (2012).","journal-title":"Neurochem. Int."},{"key":"642_CR45","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3892\/ijmm.2014.1904","volume":"34","author":"DW Li","year":"2014","unstructured":"Li, D. W. et al. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson\u2019s disease. Int. J. Mol. Med. 34, 1358\u20131364 (2014).","journal-title":"Int. J. Mol. Med."},{"key":"642_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12640-018-9976-1","volume":"35","author":"NF Marques","year":"2019","unstructured":"Marques, N. F., Massari, C. M. & Tasca, C. I. Guanosine protects striatal slices against 6-OHDA-induced oxidative damage, mitochondrial dysfunction, and ATP depletion. Neurotox. Res. 35, 475\u2013483 (2019).","journal-title":"Neurotox. Res."},{"key":"642_CR47","doi-asserted-by":"publisher","first-page":"147080","DOI":"10.1016\/j.brainres.2020.147080","volume":"1748","author":"Y Nonose","year":"2020","unstructured":"Nonose, Y. et al. Guanosine enhances glutamate uptake and oxidation, preventing oxidative stress in mouse hippocampal slices submitted to high glutamate levels. Brain Res. 1748, 147080 (2020).","journal-title":"Brain Res."},{"key":"642_CR48","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11011-014-9548-x","volume":"29","author":"LG Paniz","year":"2014","unstructured":"Paniz, L. G. et al. Neuroprotective effects of guanosine administration on behavioral, brain activity, neurochemical and redox parameters in a rat model of chronic hepatic encephalopathy. Metab. Brain Dis. 29, 645\u2013654 (2014).","journal-title":"Metab. Brain Dis."},{"key":"642_CR49","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.bbi.2012.03.007","volume":"26","author":"F Petronilho","year":"2012","unstructured":"Petronilho, F. et al. Protective effects of guanosine against sepsis-induced damage in rat brain and cognitive impairment. Brain Behav. Immun. 26, 904\u2013910 (2012).","journal-title":"Brain Behav. Immun."},{"key":"642_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jnc.12694","volume":"130","author":"A Quincozes-Santos","year":"2014","unstructured":"Quincozes-Santos, A. et al. Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1. J. Neurochem. 130, 61\u201374 (2014).","journal-title":"J. Neurochem."},{"key":"642_CR51","first-page":"297","volume":"24","author":"A Tarozzi","year":"2010","unstructured":"Tarozzi, A. et al. Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by amyloid-beta peptide oligomers. J. Biol. Regul. Homeost. Agents 24, 297\u2013306 (2010).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"642_CR52","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11302-016-9534-3","volume":"12","author":"DT Thomaz","year":"2016","unstructured":"Thomaz, D. T. et al. Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen\/glucose deprivation. Purinergic Signal. 12, 707\u2013718 (2016).","journal-title":"Purinergic Signal."},{"key":"642_CR53","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11302-019-09679-w","volume":"15","author":"T Dal-Cim","year":"2019","unstructured":"Dal-Cim, T. et al. Guanosine prevents oxidative damage and glutamate uptake impairment induced by oxygen\/glucose deprivation in cortical astrocyte cultures: involvement of A1 and A2A adenosine receptors and PI3K, MEK, and PKC pathways. Purinergic Signal. 15, 465\u2013476 (2019).","journal-title":"Purinergic Signal."},{"key":"642_CR54","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11302-019-09677-y","volume":"15","author":"H Decker","year":"2019","unstructured":"Decker, H. et al. Guanosine and GMP increase the number of granular cerebellar neurons in culture: dependence on adenosine A2A and ionotropic glutamate receptors. Purinergic Signal. 15, 439\u2013450 (2019).","journal-title":"Purinergic Signal."},{"key":"642_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/iju.12652","volume":"22","author":"M Nomiya","year":"2015","unstructured":"Nomiya, M., Andersson, K. E. & Yamaguchi, O. Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms. Int. J. Urol. 22, 40\u201346 (2015).","journal-title":"Int. J. Urol."},{"key":"642_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11884-010-0057-4","volume":"5","author":"KE Andersson","year":"2010","unstructured":"Andersson, K. E., Fulhase, C., Soler, R. & Suimaraes-Souza, N. K. Update on uropharmacology: bladder dysfunction, nitric oxide, and reactive oxygen species. Curr. Bladder Dysfunct. Rep. 5, 150\u2013156 (2010).","journal-title":"Curr. Bladder Dysfunct. Rep."},{"key":"642_CR57","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.urology.2008.10.032","volume":"73","author":"F Liu","year":"2009","unstructured":"Liu, F. et al. Protective effects of inosine on urinary bladder function in rats with partial bladder outlet obstruction. Urology 73, 1417\u20131422 (2009).","journal-title":"Urology"},{"key":"642_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141492","volume":"10","author":"YG Chung","year":"2015","unstructured":"Chung, Y. G. et al. Inosine Improves neurogenic detrusor overactivity following spinal cord injury. PLoS One 10, e0141492 (2015).","journal-title":"PLoS One"},{"key":"642_CR59","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1073\/pnas.132076299","volume":"99","author":"P Chen","year":"2002","unstructured":"Chen, P., Goldberg, D. E., Kolb, B., Lanser, M. & Benowitz, L. I. Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc. Natl Acad. Sci. USA 99, 9031\u20139036 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"642_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neulet.2007.11.072","volume":"431","author":"R Chang","year":"2008","unstructured":"Chang, R., Algird, A., Bau, C., Rathbone, M. P. & Jiang, S. Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci. Lett. 431, 101\u2013105 (2008).","journal-title":"Neurosci. Lett."},{"key":"642_CR61","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.3892\/mmr.2017.6521","volume":"15","author":"G Deng","year":"2017","unstructured":"Deng, G., Qiu, Z., Li, D., Fang, Y. & Zhang, S. Delayed administration of guanosine improves long-term functional recovery and enhances neurogenesis and angiogenesis in a mouse model of photothrombotic stroke. Mol. Med. Rep. 15, 3999\u20134004 (2017).","journal-title":"Mol. Med. Rep."},{"key":"642_CR62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11302-015-9489-9","volume":"12","author":"DB Ramos","year":"2016","unstructured":"Ramos, D. B. et al. Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats. Purinergic Signal. 12, 149\u2013159 (2016).","journal-title":"Purinergic Signal."},{"key":"642_CR63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainres.2011.06.027","volume":"1407","author":"MP Rathbone","year":"2011","unstructured":"Rathbone, M. P. et al. Systemic administration of guanosine promotes functional and histological improvement following an ischemic stroke in rats. Brain Res. 1407, 79\u201389 (2011).","journal-title":"Brain Res."},{"key":"642_CR64","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1172\/JCI13018","volume":"108","author":"KJ Kelly","year":"2001","unstructured":"Kelly, K. J., Plotkin, Z. & Dagher, P. C. Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J. Clin. Invest. 108, 1291\u20131298 (2001).","journal-title":"J. Clin. Invest."},{"key":"642_CR65","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/ACI.0000000000000006","volume":"13","author":"E Grunebaum","year":"2013","unstructured":"Grunebaum, E., Cohen, A. & Roifman, C. M. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies. Curr. Opin. Allergy Clin. Immunol. 13, 630\u2013638 (2013).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"642_CR66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s004390050787","volume":"103","author":"Y Sasaki","year":"1998","unstructured":"Sasaki, Y. et al. Direct evidence of autosomal recessive inheritance of Arg24 to termination codon in purine nucleoside phosphorylase gene in a family with a severe combined immunodeficiency patient. Hum. Genet. 103, 81\u201385 (1998).","journal-title":"Hum. Genet."},{"key":"642_CR67","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3389\/fimmu.2020.01257","volume":"11","author":"E Grunebaum","year":"2020","unstructured":"Grunebaum, E., Campbell, N., Leon-Ponte, M., Xu, X. & Chapdelaine, H. Partial purine nucleoside phosphorylase deficiency helps determine minimal activity required for immune and neurological development. Front. Immunol. 11, 1257 (2020).","journal-title":"Front. Immunol."},{"key":"642_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2152\/jmi.51.146","volume":"51","author":"N Ohtani","year":"2004","unstructured":"Ohtani, N., Yamakoshi, K., Takahashi, A. & Hara, E. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J. Med. Invest. 51, 146\u2013153 (2004).","journal-title":"J. Med. Invest."},{"key":"642_CR69","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","volume":"21","author":"BG Childs","year":"2015","unstructured":"Childs, B. G., Durik, M., Baker, D. J. & vanDeursen, J. M. Cellular senescence in aging and age-related disease from mechanisms to therapy. Nat. Med. 21, 1424\u20131435 (2015).","journal-title":"Nat. Med."},{"key":"642_CR70","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232\u2013236 (2011).","journal-title":"Nature"},{"key":"642_CR71","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00345-020-03492-6","volume":"39","author":"LA Birder","year":"2021","unstructured":"Birder, L. A. et al. A uro-protective agent with restorative actions on urethral and striated muscle morphology. World J. Urol. 39, 2685\u20132690 (2021).","journal-title":"World J. Urol."},{"key":"642_CR72","first-page":"3910394","volume":"82","author":"MM Wickremaratchi","year":"2005","unstructured":"Wickremaratchi, M. M. & Llewelyn, J. G. Effects of ageing on touch. Postgrad. Med. J. 82, 3910394 (2005).","journal-title":"Postgrad. Med. J."},{"key":"642_CR73","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/antiox10050673","volume":"10","author":"G Zalba","year":"2021","unstructured":"Zalba, G. Oxidative stress in vascular pathophysiology: still much to learn. Antioxidants 10, 673 (2021).","journal-title":"Antioxidants"},{"key":"642_CR74","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11255-008-9492-y","volume":"41","author":"YS Juan","year":"2009","unstructured":"Juan, Y. S. et al. Effect of ischemia\/reperfusion on bladder nerve and detrusor cell damage. Int. Urol. Nephrol. 41, 513\u2013521 (2009).","journal-title":"Int. Urol. Nephrol."},{"key":"642_CR75","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1464-410X.2008.07587.x","volume":"102","author":"GM Pinggera","year":"2008","unstructured":"Pinggera, G. M. et al. Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography. BJU Int. 102, 470\u2013474 (2008).","journal-title":"BJU Int."},{"key":"642_CR76","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1159\/000368576","volume":"61","author":"BA Monk","year":"2015","unstructured":"Monk, B. A. & George, S. J. The effect of ageing on vascular smooth muscle cell behavior. Gerontology 61, 416\u2013426 (2015).","journal-title":"Gerontology"},{"key":"642_CR77","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10237-017-0968-5","volume":"17","author":"F Cheng","year":"2018","unstructured":"Cheng, F. et al. Layer dependent role of collagen recruitment during loading of the rat bladder wall. Biomech. Model. Mechanobiol. 17, 403\u2013417 (2018).","journal-title":"Biomech. Model. Mechanobiol."},{"key":"642_CR78","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.actbio.2022.01.015","volume":"141","author":"TG Tuttle","year":"2022","unstructured":"Tuttle, T. G., Lujan, H. L., Tykocki, N. R., DiCarlo, S. E. & Roccablanca, S. Remodeling of extracellular matrix in the urinary bladder of paraplegic rats results in increased compliance and delayed fiber recruitment 16 weeks after spinal cord injury. Acta Biomater. 141, 280\u2013289 (2022).","journal-title":"Acta Biomater."},{"key":"642_CR79","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.15252\/embj.201593084","volume":"35","author":"D Sebastian","year":"2016","unstructured":"Sebastian, D. Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. EMBO J. 35, 1677\u20131682 (2016).","journal-title":"EMBO J."},{"key":"642_CR80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1534-5807(01)00055-7","volume":"1","author":"S Frank","year":"2001","unstructured":"Frank, S., Gaume, B. & Bergmann-Leitner, E. W. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1, 515\u2013525 (2001).","journal-title":"Dev. Cell"},{"key":"642_CR81","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00441-016-2485-8","volume":"367","author":"C Rub","year":"2017","unstructured":"Rub, C., Wilkening, A. & Voos, W. Mitochondrial quality control by the Pink1\/Parkin system. Cell Tissue Res. 367, 111\u2013123 (2017).","journal-title":"Cell Tissue Res."},{"key":"642_CR82","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter, A. G. & Janicke, R. U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6, 99\u2013110 (1999).","journal-title":"Cell Death Differ."},{"key":"642_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-8-31","volume":"8","author":"G Chaitanya","year":"2010","unstructured":"Chaitanya, G., Alexander, J. S. & Babu, P. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal. 8, 31 (2010).","journal-title":"Cell Commun. Signal."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-022-00642-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-022-00642-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-022-00642-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T14:33:00Z","timestamp":1667399580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-022-00642-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1038\/s41585-022-00642-w","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"1 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Both authors are co-inventors on a (pending) patent, PCT\/US2020\/022697, which relates to the field of purine nucleoside phosphorylase (PNPase) inhibitors and PNPase purine nucleoside substrates for treating bladder and urethra dysfunction or disease.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}